GlobeNewswire Inc | Jul 29, 2021 08:30AM EDT

July 29, 2021

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the fourth quarter and full year ended June 30, 2021, shortly after the NASDAQ market close on Wednesday, August 11. Management will then host a conference call and webcast at 4:30 p.m. ET.

GBS,Inc. Fourth Quarter 2021 and Full Year FinancialTitle: Results Conference Call & WebcastDate: Wednesday, August 11, 2021 Time: 4:30 p.m. ET Conference Toll-Free: 877-407-3982Call Details: International: 201-493-6780 Conference ID: 13721414The conference call will be webcast live from the Company?s website and willbe available via the following links:

http://public.viavid.com/index.php?id=145701Webcast: https://investors.gbs.inc/news-and-events/investor-calendar

The webcast should be accessed 15 minutes prior to the conference call starttime. A replay of the webcast will be available following the conclusion of thelive broadcast and will be accessible on the Company?s website.

About GBS Inc.GBS Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help people living with diabetes.

For more information, please visit GBS.inc or follow GBS Inc. onTwitterandLinkedIn.

Investor Contact:LifeSci Advisors, LLCJeremy Feffer - Managing Director212-915-2568jeremy@lifesciadvisors.com

Company Contact:The iQ Group GlobalAlex Arzeno - VP Investor Relationsalex.arzeno@theiqgroupglobal.com